Thursday, 18 July 2019

Pharma News

  • Phylogica, Cubist evaluate antimicrobial phylomers

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jul, 2013

    Singapore: Phylogica is collaborating with Cubist Pharmaceuticals in order to evaluate several of its antimicrobial Phylomers in models of multi-drug resistant bacterial infections. Dr Paul...Read more

  • Sucampo gets $15 mn payment from Abbott

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2012

    Singapore: Sucampo Pharmaceuticals' subsidiary SPL has received a $15 million milestone payment from Abbott's subsidiary, Abbott Japan, pursuant to the existing license, commercialization ...Read more

  • Mylan resolves Brovana patent litigation

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 25 May, 2012

    Singapore: Mylan Specialty, which was formerly known as Dey Pharma, entered into a deal with Sunovion Pharmaceuticals, to resolve the patent litigation relating to Sunovion's Brovana produ...Read more

  • Kevin Buchi joins Benitec board

    Pharma |  Influencers | By BioSpectrum Bureau  | 0 Comment | 11 Apr, 2013

    Singapore: Benitec Biopharma appointed Mr Kevin Buchi to its board of directors. Mr Buchi served as CEO of Cephalon, through its $6.8 billion acquisition by Teva Pharmaceutical Industries i...Read more

  • Shengtai Pharma reports FY 2012 results

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2012

    Singapore: Shengtai Pharmaceutical, a manufacturer and distributor of glucose and starch in China, reported financial results for the twelve months ended June 30, 2012. Sales revenue for ...Read more

  • A*STAR, GSK develop medicines for emerging markets

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 09 Apr, 2013

    Singapore: GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical and Engineering Sciences (ICES) have signed a five-year strategic agreement to develop new evidence based formulations (E...Read more

  • Aussie firm gets TGA approval for pancreatic cancer drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2014

    Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has recieved Therapeutic Goods Administration (TGA) approval for ABRAXANE (nanoparticle albumin-bo...Read more

  • AIDS 2014: Bill Clinton urges efficient routes for HIV treatment

    Pharma |  Influencers | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2014

    Singapore: Former US President Bill Clinton addressed delegates at AIDS 2014, 20th International AIDS Conference, that finding more economically efficient ways to respond to HIV is vital to...Read more

  • What the UK plans to do at Bangalore India BIO?

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2014

    A positive business environment, access to global expertise and the presence of world renowned universities, is helping the UK to nurture some of the most innovative companies. Life science...Read more

  • Scotland approves Eisai's Fycompa

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Eisai announched that Scotland's health technology assessment (HTA) body, the Scottish Medicines Consortium (SMC), has approved Eisai's AMPA receptor antagonist Fycompa (perampa...Read more

  • India's new pharma pricing policy will be a profitability challenge: Glenn Saldanha

    Pharma |  Opinion | By BioSpectrum Bureau  | 0 Comment | 20 May, 2013

    The Indian pharmaceutical industry has witnessed a healthy growth in the last decade, driven by factors like rising consumption levels in the country and strong demand from export markets. ...Read more

  • RLS, Parkinson's drug Neupro gets Japanese nod

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Dec, 2012

    Singapore: The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Neupro (rotigotine transdermal patch) for the treatment of Parkinson's disease (PD) and for the symptomat...Read more

  • AVEO, Astellas cancer drug gets FDA nod

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2012

    Singapore: AVEO Oncology and Astellas Pharma announced that the US Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for tivozanib with the propo...Read more

  • Mundipharma, Shionogi tie up for pain treatment in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 22 Nov, 2013

    Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, manufacture and commercialize the abuse deterrent formulation of Oxycod...Read more

  • China Biologic adopts stockholder rights plan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announced that its board of directors has adopted a stockholder rights plan....Read more

  • Cipla acquires 51 percent stake in Yemen

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2014

    Singapore: Given the recent preference to local manufacturing, this secures the company's presence in a fast growing market. Cipla already has a leading position in Yemen with over 200 pro...Read more

  • Bayer to buy Chinese firm Dihon Pharma

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2014

    Singapore: Germany's leading pharmaceutical company, Bayer has said that it is planning to acquire Chinese pharma firm Dihon Pharmaceutical Group as part of its global growth plan. The pha...Read more

  • ScinoPharm CEO retires, firm's VP to succeed

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jul, 2014

    Singapore: Taiwan-based pharmaceutical company ScinoPharm announced the retirement of its chief executive officer, Dr Jo Shen. Dr Shen would be retiring by the end of July, following 17 yea...Read more



Podcast

 

Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls